GuidesPeptidesLast checked August 24, 2026No dosing

Wolverine, GLOW and KLOW: what's actually in them, and what's known

Four peptides, three shopping baskets, one published human trial between them. What each one is, where the evidence stops, and the trade you make when you stack them.

Regulatory status here is moving, so check again before relying on any of it.

Four peptides, four questionsWhat's behind each, as of Aug 2026
Is there…BPC-157TB-500GHK-CuKPV
A published human RCTfor any indication✕✕~✕
Animal studies✓✓✓✓
Approved for human useas a drug, anywhere✕✕~✕
Allowed in tested sport✕✕
yes partly, topical only no
A tick is a yes, a cross is a no, a tilde is a partial: GHK-Cu's human trials are topical, and its approval is as a cosmetic ingredient. Dashed is not on the list either way.

If you've found your way to these, it's usually because of one of a few things: a tendon that hasn't come right in eight months, a shoulder that clicks, a knee that flares every time training gets serious again, a gut problem nobody has solved, or a surgery you want to come back from faster than the last one. Often it's someone in their thirties or forties who used to recover from things and now doesn't.

That problem is real, and conventional medicine isn't very good at it. Chronic tendinopathy is a case in point. The honest answer from sports medicine is often loading programmes, patience, and a shrug: injections that haven't outperformed placebo, imaging that looks fine while it still hurts, and a timeline measured in seasons. When the official answer is "wait, and keep doing your eccentrics", a bottle promising accelerated healing doesn't need to be very convincing to be more appealing than that.

What the marketing claims

I'll state it fairly, because the claims are specific rather than vague, and that's part of why they land:

  • Systemic healing: that BPC-157 accelerates repair of tendon, ligament, muscle and gut lining, and works wherever it's needed rather than only at the injection site.
  • New blood supply: that both BPC-157 and TB-500 promote angiogenesis. That's a real bottleneck in tendon healing, since tendons are poorly vascularised and that's a genuine reason they heal slowly.
  • Skin and collagen: GHK-Cu, which is where GLOW gets both its name and its appearance-focused pitch.
  • Calmer inflammation: KPV, added in KLOW, usually pitched at gut inflammation and skin.
  • Remarkable safety: "no reported side effects", a claim that sounds like a finding and is in fact a description of how little anyone has looked.

You'll also see the framing that these are "what pro athletes use", the nickname "Wolverine" doing obvious work, and a lot of citations to studies, which, as below, are almost entirely rodent studies from one laboratory.

None of that is invented from nothing. The mechanisms described are real mechanisms, and the preclinical results people cite exist. This page is about a narrower question: what happens when you move from "this does something interesting in a rat tendon" to "this will fix your shoulder", and how much of the confidence in between is actually earned.

First, a "stack" is just several peptides at once

Each of these four is a separate compound with its own history, and each is sold on its own. A stack is a pre-mixed vial containing several of them together, sold under one name. Wolverine, GLOW and KLOW aren't different drugs, they're different shopping baskets.

Why someone takes them separately

  • One problem, one tool. Someone with a gut issue is interested in BPC-157 and has no reason to buy the copper peptide. Someone chasing skin wants GHK-Cu and nothing else.
  • You can tell what did what. Change one thing and any effect, good, bad, or a reaction, has one candidate explanation. This is the single biggest practical argument, and it's the one most often given up first.
  • Independent control. Different components have different intended timelines. Fixed in a blend, you can't stop one, extend another, or change the ratio without discarding the vial.
  • Cost. Buying one is cheaper than buying four, particularly if three of them aren't aimed at your problem.

Why someone takes them stacked

  • One injection instead of four. Not a small thing. Adherence to anything self-injected falls off sharply with the number of separate steps, and a single vial is the difference between doing it and not.
  • The layered theory. The pitch is that each addresses a different layer of the same repair process (tissue, blood supply, collagen remodelling, inflammation), so the combination should do more than the parts. It's plausible reasoning. It's also entirely reasoning, see below.
  • Simplicity and price. One purchase, one reconstitution, one number to remember, and a blend usually costs less than the four bought individually.

The trade is straightforward once you state it: convenience in exchange for knowing anything. With four things at once, if it helps you can't say what helped, and if something goes wrong you can't say what caused it. You're left discontinuing all four and starting over. In a category where the individual evidence is as thin as it is below, giving up your own ability to observe is a steeper price than it looks.

Two things worth knowing before the details.

These names come from sellers, not from researchers. "Wolverine", "GLOW" and "KLOW" are product names for pre-mixed vials. They aren't clinical protocols, they weren't designed in a trial, and no study has ever tested any of these combinations. Whatever is known about each peptide individually isn't evidence about them together.

This page has no dosing information. Every other result for these terms is a "protocol" published by somebody selling the vials. Selfsense records what you enter and never tells you what to take, and I'm holding this page to the same rule.

What each stack contains

BPC-157TB-500GHK-CuKPV
Wolverine
BPC-157TB-500
The base pair. Both are studied in soft-tissue repair and blood-vessel formation models.
GLOW
BPC-157TB-500GHK-Cu
Adds the copper peptide, which is where the skin and collagen claims come from.
KLOW
BPC-157TB-500GHK-CuKPV
Adds KPV, a tripeptide studied for inflammation. The broadest of the three.

They're nested: GLOW is Wolverine plus one, KLOW is GLOW plus one. So the real question isn't which stack is "best", it's how many unstudied variables you're willing to introduce at once. Every addition makes it harder to know what caused any effect you notice, good or bad.

What each peptide is, and what's behind it

BPC-157 Not approved for human use

A synthetic fragment derived from a protein found in gastric juice. Studied for tendon, ligament, gut and muscle healing.

Evidence: There's no published randomised controlled trial in humans, for any indication. A 2025 systematic review in the American Journal of Sports Medicine screened 544 articles and found exactly one clinical study, and the other 35 were animal models. Human safety data amounts to a 2025 IV pilot in two people.

Status: Not approved as a drug in Canada or the US. Banned by WADA at all times (category S0). US compounding status is in flux. In Canada it can be compounded orally on a prescription despite being unauthorised as an injectable, which is why its status confuses people.

TB-500 Not approved for human use

A synthetic fragment of thymosin beta-4, a protein involved in cell migration and wound repair.

Evidence: Weaker than BPC-157's, which is saying something. It's almost entirely preclinical. The parent protein has been trialled in humans for some indications, but the fragment sold as TB-500 hasn't been established as equivalent.

Status: No regulator anywhere (Health Canada, FDA, EMA, MHRA, TGA) has authorised it for human or veterinary use. Banned by WADA.

GHK-Cu Regulated topically, not as an injectable

A copper-binding tripeptide found naturally in plasma. Well established in skin research for collagen and remodelling.

Evidence: The strongest of the four, but for topical use. It's a mainstream, extensively studied cosmetic ingredient. Injected GHK-Cu is a different question with far less behind it.

Status: Regulated and legal as a cosmetic ingredient in topical products. Injectable GHK-Cu isn't an approved drug anywhere. That distinction matters more than almost anything else on this page.

KPV Not approved for human use

A three-amino-acid fragment of alpha-MSH, studied for anti-inflammatory effects, particularly in the gut.

Evidence: Preclinical. No human efficacy trials of consequence.

Status: Not approved anywhere. It was on the FDA's July 2026 agenda for compounding review, alongside BPC-157, TB-500 and MOTS-C.

"It really chilled me out", the effect people report that nobody advertises

This comes up constantly and almost never in the marketing, which sells tendons and skin. People on these, KLOW especially but also plain BPC-157, frequently report feeling calmer, less irritable, better able to sleep. I think it's worth taking seriously rather than waving away, and worth understanding why the usual explanation for it is wrong.

The gut-serotonin explanation is half right, in the half that doesn't matter

The version you'll hear is that most of your serotonin is made in your gut, these peptides heal your gut, so they lift your mood. The first part is true. Roughly 90 to 95% of the body's serotonin is made in the gut, by enterochromaffin cells, not in the brain.

The problem is the next step. Gut serotonin doesn't cross the blood-brain barrier. It's a functionally separate pool doing a different job: gut motility, digestive reflexes, the enteric nervous system. Your brain synthesises its own. So "most of your serotonin is in your gut" is a real fact that doesn't support the conclusion people hang on it, and any seller using it as the mechanism is repeating something they haven't checked.

What could be going on

  • BPC-157 acting on the brain directly, the strongest candidate. There's a genuine body of rodent work here: anxiolytic effects in elevated plus-maze testing, antidepressant-like effects in forced-swim and learned-helplessness models, and reported effects on dopamine and serotonin systems including raised hippocampal serotonin. Note the irony, the preclinical mood literature is arguably better developed than the tendon literature it's actually sold for. All rodent. No human trial for any psychiatric endpoint.
  • The gut-brain axis, by the real routes. The connection is genuine, just not via serotonin travelling north. It runs through vagal signalling, immune and inflammatory pathways, and tryptophan availability. Gut inflammation demonstrably affects mood, so something that reduced it plausibly could too. Plausibly.
  • Simply hurting less. Chronic pain is exhausting and corrosive to mood in a way people stop noticing until it lifts. If the shoulder is better, you're calmer, and no novel mechanism is required.
  • Expectation. Calm and irritability are subjective, they fluctuate anyway, and they respond to believing you're doing something about your health. This is the hardest one to rule out, and it's doing more work than most people credit.

One detail argues against the tidiest theory. KPV, the anti-inflammatory component people usually point at, is in KLOW but not GLOW. If both produce the effect, KPV isn't the explanation, and the common factor is BPC-157, which is in everything including the plain vials.

Nobody has tested any of this in people. Here's what I think is fair to say: it's reported often enough to be worth noting, the mechanism usually given for it is wrong, at least one real mechanism exists that could account for it, and none of that has been demonstrated in a human. If it's the effect you're actually after, that's worth knowing about yourself, because it isn't what you're being sold, and there are treatments for it with evidence behind them.

"But my naturopath prescribed it"

People are prescribed BPC-157 and TB-500 by Canadian practitioners. That's happening, and it doesn't mean the substances are approved. A prescription is a practitioner's decision, while approval is a finding that something was assessed. The route is compounding, which is regulated by provincial pharmacy colleges rather than by Health Canada, and it's a gap the colleges have started closing.

It's enough of a subject that I gave it its own page: how unapproved drugs get prescribed in Canada. It covers what the rules require, why the oral and injectable forms sit differently, and the three questions worth asking whoever is prescribing.

If you're tested in sport, stop here

BPC-157 and TB-500 are both on the WADA Prohibited List, banned at all times, in and out of competition. This applies at essentially every level that tests, including masters and amateur events far below the professional tier. A US regulatory change to compounding status wouldn't alter this, because WADA maintains its own list independently of the FDA.

And the tendon that started this

I'd be writing a poor guide if I spent this long on why the appealing answer is unproven and never came back to the actual problem. The unglamorous option does have evidence behind it. Progressive loading, heavy, slow, structured, and continued for months rather than weeks, is the best-supported treatment for most chronic tendinopathy. It gets abandoned early because it's boring, and because it's normal for it to hurt somewhat while it works. A physiotherapist who programmes it properly is a different experience from being told to do some stretches.

None of which proves the peptides do nothing. Absence of evidence isn't evidence of absence, and what would settle it is ordinary: a published human trial, from a group independent of the original lab, showing an effect on something that matters. Until that exists, nobody knows, including the people selling it and anyone who tells you otherwise.

What's worth weighing in the meantime is the asymmetry. On one side, a treatment that's dull, slow, well evidenced and free. On the other, a vial whose entire human safety record is two people. I'd exhaust the first before paying for the second.

Selfsense

If you're running something and want to see what happened over months rather than relying on memory, Selfsense logs what you took, when, where you injected, and how it went, and plots it against your own measurements.

Open your record →

General information, not medical advice, and not a recommendation to use any substance described here. Most of what's on this page isn't approved for human use in Canada or anywhere else. Talk to a licensed healthcare professional.